Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc.（XTNT）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · XTNT · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
1
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Xtant Medical Holdings, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
XTNT 季度内部人买卖趋势
XTNT 内幕交易卖出 · XTNT 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · XTNT CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
XTNT 高管卖出股份 · XTNT 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Feb 15, 2026 | Schallenberger Mark A. COO | Other | 7,709 | $4K | Form 4 |
| Jan 15, 2026 | Neils Scott C CFO and Assistant Secretary | Other | 8,084 | $5K | Form 4 |
| Nov 15, 2025 | Vizirgianakis Stavros G. Director | Award | 553,797 | — | Form 4 |
| Nov 15, 2025 | Beeson Jonn R. Director | Award | 158,228 | — | Form 4 |
| Nov 15, 2025 | BAKEWELL JOHN K Director | Award | 158,228 | — | Form 4 |
| Nov 15, 2025 | JAIN ABHINAV Director | Award | 158,228 | — | Form 4 |
| Nov 15, 2025 | Lipschultz Tyler Director | Award | 158,228 | — | Form 4 |
| Nov 15, 2025 | Browne Sean E President and CEO · Director | Award | 394,937 | — | Form 4 |
| Nov 15, 2025 | Schallenberger Mark A. COO | Award | 292,253 | — | Form 4 |
| Nov 15, 2025 | Neils Scott C CFO and Assistant Secretary | Award | 263,291 | — | Form 4 |
| Aug 15, 2025 | Browne Sean E President and CEO · Director | Other | 10,605 | $7K | Form 4 |
| Aug 15, 2025 | Neils Scott C CFO | Other | 34,131 | $22K | Form 4 |
| Apr 10, 2025 | ORBIMED ADVISORS LLC 10 percent owner | Sale | 17,109,618 | $7.19M⚡ | Form 4 |
| Jan 15, 2025 | Neils Scott C CFO | Other | 7,986 | $4K | Form 4 |
| Oct 15, 2024 | Browne Sean E President and CEO · Director | Other | 105,442 | $62K | Form 4 |
| Aug 15, 2024 | Vizirgianakis Stavros G. Director | Award | 505,405 | — | Form 4 |
| Aug 15, 2024 | Vizirgianakis Stavros G. Director | Award | 243,243 | — | Form 4 |
| Aug 15, 2024 | MITCHELL-KELLER LORI D Director | Award | 162,162 | — | Form 4 |
| Aug 15, 2024 | McNamara Robert Director | Award | 162,162 | — | Form 4 |
| Aug 15, 2024 | Beeson Jonn R. Director | Award | 162,162 | — | Form 4 |
| Aug 15, 2024 | BAKEWELL JOHN K Director | Award | 162,162 | — | Form 4 |
| Aug 15, 2024 | Brandt Kevin D Chief Commercial Officer | Other | 56,333 | $34K | Form 4 |
| Aug 15, 2024 | Neils Scott C CFO | Other | 34,132 | $20K | Form 4 |
| Aug 15, 2024 | Browne Sean E President and CEO · Director | Other | 10,606 | $6K | Form 4 |
| Apr 3, 2024 | Brandt Kevin D Chief Commercial Officer | Award | 184,209 | — | Form 4 |
ORBIMED ADVISORS LLC
10 percent owner
日期
Apr 10
股数
17,109,618
均价
$0.42
总金额
$7.19M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 XTNT 内幕交易
XTNT 内幕交易
Xtant Medical Holdings, Inc.（XTNT）内幕交易数据来源于公司内部人（包括Neils Scott C (CFO and Assistant Secretary), Schallenberger Mark A. (COO), Browne Sean E (President and CEO · Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。XTNT内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Xtant Medical Holdings, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
XTNT 内幕交易 · 5个问题Xtant Medical Holdings, Inc.（XTNT）的内部人包括高管和董事，如Neils Scott C (CFO and Assistant Secretary), Schallenberger Mark A. (COO), Browne Sean E (President and CEO · Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026